Citius Oncology, Inc.
CTOR · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $99,458 | $1,022,755 | $1,030,529 | $930,402 |
| - Cash | $0 | $27 | $289 | $0 |
| + Debt | $3,800 | $0 | $0 | $0 |
| Enterprise Value | $103,258 | $1,022,728 | $1,030,240 | $930,402 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$20,573 | -$12,121 | -$4,857 | -$10 |
| % Margin | – | – | – | – |
| Net Income | -$21,149 | -$12,697 | -$5,433 | -$10 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.3 | -0.19 | -0.076 | -0.001 |
| % Growth | -57.9% | -149% | -6,258.3% | – |
| Operating Cash Flow | $126 | -$601 | -$48 | – |
| Capital Expenditures | -$5,000 | $0 | $0 | – |
| Free Cash Flow | -$4,874 | -$601 | -$48 | – |